A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä
Prevalence of Age-Related Macular Degeneration in Europe: The Past and the Future
Tekijät: Colijn JM, Buitendijk GHS, Prokofyeva E, Alves D, Cachulo ML, Khawaja AP, Cougnard-Gregoire A, Merle BMJ, Korb C, Erke MG, Bron A, Anastasopoulos E, Meester-Smoor MA, Segato T, Piermarocchi S, de Jong PTVM, Vingerling JR, Topouzis F, Creuzot-Garcher C, Bertelsen G, Pfeiffer N, Fletcher AE, Foster PJ, Silva R, Korobelnik JF, Delcourt C, Klaver CCW; EYE-RISK consortium; European Eye Epidemiology (E3) consortium
Julkaisuvuosi: 2017
Journal: Ophthalmology: Journal of The American Academy of Ophthalmology
Vuosikerta: 124
Numero: 12
Aloitussivu: 1753
Lopetussivu: 1763
Sivujen määrä: 11
ISSN: 0161-6420
DOI: https://doi.org/10.1016/j.ophtha.2017.05.035
Conclusion
We observed a decreasing prevalence of AMD and an improvement in visual acuity in CNV occuring over the past 2 decades in Europe. Healthier lifestyles and implementation of anti–vascular endothelial growth factor treatment are the most likely explanations. Nevertheless, the numbers of affected subjects will increase considerably in the next 2 decades. AMD continues to remain a significant public health problem among Europeans.
